I'm LongbridgeAI, I can summarize articles.Nature's Sunshine (NATR) reports Q2 earnings after market close. Last quarter, the company beat revenue, EPS, and EBITDA estimates. Analysts expect 7.8% YoY revenue growth this quarter, with estimates largely confirmed. While peers like Medifast and USANA reported mixed results, investor sentiment in the personal care segment remains positive. NATR shares are down 5.6% recently, trading below the $34.50 average analyst price target.
Wellness products company Nature’s Sunshine will be reporting earnings this Thursday after the bell. Here’s what to expect.
Nature's Sunshine beat analysts’ revenue expectations last quarter, reporting revenues of $122.9 million, up 8.5% year on year. It was a strong quarter for the company, with a beat of analysts’ EPS estimates and an impressive beat of analysts’ EBITDA estimates.
Is Nature's Sunshine a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.
This quarter, the market is expecting Nature's Sunshine’s revenue to grow 7.8% year on year, improving from the 3.8% increase it recorded in the same quarter last year.
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business will stay the course heading into earnings. Nature's Sunshine rarely misses Wall Street’s revenue estimates.
Looking at Nature's Sunshine’s peers in the personal care segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Medifast’s revenues decreased 27.6% year on year, beating analysts’ expectations by 5.1%, and USANA reported a revenue decline of 5.4%, falling short of estimates by 5.1%. Medifast traded up 33.9% following the results.
Read our full analysis of Medifast’s results here and USANA’s results here.
There has been positive sentiment among investors in the personal care segment, with share prices up 2.8% on average over the last month. Nature's Sunshine is down 5.6% during the same time and is heading into earnings with an average analyst price target of $34.50 (compared to the current share price of $20.45).
ALSO WORTH WATCHING: Nvidia’s Quiet Partner. Nvidia’s chips cost a hundred grand. The connectors that make them work cost even more. One company makes them all.
Every AI server needs specialized infrastructure the chip companies don’t make. High-speed cables. Power connectors. Thermal sensors. This 90-year-old company built a monopoly on it. The AI boom just started. This stock is still flying under the radar.